300878 维康药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.191-21.986-11.571-0.6423.492
总资产报酬率 ROA (%)0.137-15.660-7.939-0.4502.706
投入资产回报率 ROIC (%)0.154-17.751-8.857-0.4963.001

边际利润分析
销售毛利率 (%)59.49931.06538.18250.52358.854
营业利润率 (%)13.550-89.466-43.777-0.36612.180
息税前利润/营业总收入 (%)8.938-90.350-43.2860.17012.485
净利润/营业总收入 (%)2.646-101.979-41.253-1.3669.293

收益指标分析
经营活动净收益/利润总额(%)182.88447.745100.957599.87060.840
价值变动净收益/利润总额(%)4.6085.986-57.567-256.84923.418
营业外收支净额/利润总额(%)-65.0113.3252.86471.479-2.694

偿债能力分析
流动比率 (X)1.9452.0672.5652.3612.503
速动比率 (X)1.6981.7392.0722.0152.220
资产负债率 (%)28.11126.17428.95931.69926.298
带息债务/全部投入资本 (%)17.40011.89617.68322.11816.927
股东权益/带息债务 (%)449.729700.532445.687338.007471.542
股东权益/负债合计 (%)252.041277.994241.938212.777277.632
利息保障倍数 (X)12.308-41.200-24.2940.11719.990

营运能力分析
应收账款周转天数 (天)160.194197.295179.228167.576218.148
存货周转天数 (天)184.525207.707225.604189.431202.341